… but cannot distinguish subtypes, and this is a major limit for their use in IPF diagnosis; however,
… In animal models of lung fibrosis, treatment with nintedanib is preventive and therapeutic …

… , the subtypes of IPF … subtypes of IPF obtained in the preliminary screening of this study
have certain guiding significance for development of new drugs, clinical treatment, and prognosis …

… causes implied for the specific subtypes. The causes of some subtypes are now known: giant-…
, IPF included several histopathological subtypes of interstitial lung disease, such as usual …

… , and treatment options available for patients with idiopathic … has improved understanding
of the mechanisms of lung fibrosis, … of patients with other progressive fibrotic lung diseases. …

… Introduction: Idiopathic pulmonary fibrosis (IPF) is a progressive and invariable fatal interstitial
lung disease. Current antifibrotic treatment halts disease progression but does not cure …

… in the evaluation and care of patients with idiopathic pulmonary fibrosis (IPF). In addition to
… underlie susceptibility to IPF and affect prognosis have raised the possibility of personalized …

… pulmonary fibrosis, and includes a more detailed discussion of the potential points of therapeutic
attack in pulmonary fibrosis… Fibroblasts in a subtype fibrotic process include; a migratory …

… Idiopathic pulmonary fibrosis (IPF) is a progressive and almost invariably lethal disease that
… slowing disease progression with medication is possible. An improved understanding of …

… treatment of idiopathic pulmonary fibrosis, as well as all active and completed phase 2 and
3 clinical trials of nintedanib and pirfenidone for the treatment … The subtypes most commonly …

… The prognosis of patients with the usual interstitial … with idiopathic pulmonary fibrosis,
despite the same pathologic pattern. In contrast, in those with an NSIP pattern, the prognosis is …